Teradyne (TER) Tops Q2 EPS by 8c

Teradyne (NYSE: TER) reported Q2 EPS of $0.53, $0.08 better than the analyst estimate of $0.45. Revenue for the quarter came in at $513 million versus the consensus estimate of $487.6 million.

Teradyne sees Q3 2015 EPS of $0.35-$0.41, versus the consensus of $0.36. Teradyne sees Q3 2015 revenue of $450-480 million, versus the consensus of $455.0 million.

For earnings history and earnings-related data on Teradyne (TER) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c